Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19

Status unconfirmed

Conditions studied: Lung Injury, ARDS, Acute Cardiac Event, Covid19, Ultrasound, Hypoxemia, Acute Respiratory Distress Syndrome

In brief

This study seeks to define the ultrasound profile of patients with COVID-19, and document the progression of these ultrasound findings to develop prognostication and clinical decision instruments that can help guide management of patient with COVID-19. Primary aims include the development of ARDS, refractory hypoxemia, acute cardiac injury, pulmonary embolism, pneumothorax or death. Secondary aims include potential change in CT and plain film utilization given the use of POCUS, as well as emergency department and inpatient LOS (length of stay).

Key facts

Study ID: NCT05228717
Run by: Olive View-UCLA Education & Research Institute
People needed: 240
Starts: 2020-11-10
Expected to finish: 2022-06-01
Last updated by the study team: 2022-04-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Patients with confirmed COVID-19 pneumonia as the primary diagnosis, or COVID- associated acute hypoxemic respiratory failure or hypoxia (minimum O2 requirement 3L), that are being admitted from the emergency department, who either have waiver of consent, give verbal consent to participate, or have next of kin give consent for participation.

You may not qualify if…

age < 18 years old, pregnant patients, or patients that verbally refuse participation

Where it is running

UCLA-Ronald Reagan — Los Angeles, California, United States (enrolling)
Olive View-UCLA — Sylmar, California, United States (enrolling)
SUNY Downstate — New York, New York, United States (enrolling)
Temple University — Philadelphia, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.